who can benefit from Neuro Optimizer
Your doctor will determine the right semaglutide dosage and schedule based on your bodys response
Health advantages: GLP-1 medications bring down blood sugar levels, help control blood pressure, and lower the chances of heart issues
Artificial intelligence can support target identification, clinical trial design, biomarker discovery, patient stratification, real-world evidence generation, and safety monitoring
The favorable results from the placebo-controlled FLOW trial, conducted with semaglutide 1.0 mg in patients with T2D and chronic kidney disesase (CKD), are about to be disclosed, while ongoing dedicated trials will further explore the effects of OW semaglutide 2.4 mg (NCT04889183) and tirzepatide (NCT05536804) on kidney function parameters in obese/overweight individuals at high risk of CKD progression regardless of T2D